Glatimer Injection (Glatiramer Acetate) | Used in Multiple Sclerosis Relapse Prevention Therapy
Glatimer Injection contains Glatiramer Acetate, a medication used primarily in the treatment of relapsing forms of multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system.
Product Overview
Glatimer Injection is an established immunomodulatory disease-modifying therapy (DMT) widely prescribed for the long-term management of relapsing forms of multiple sclerosis (MS). Containing the active ingredient Glatiramer Acetate, this injectable medication consists of a synthetic mixture of four natural amino acids that structurally mimic myelin basic protein—a primary component of the protective nerve sheaths in the central nervous system. By acting as a decoy for the immune system, Glatimer shifts the body’s immune response away from attacking its own nerve fibers. It is clinically utilized to reduce the frequency of relapse episodes and slow the accumulation of physical disability in patients dealing with active neurological inflammation.
Product Composition
- Active Pharmaceutical Ingredient: Glatiramer Acetate (a synthetic polypeptide mixture of L-glutamic acid, L-alanine, L-tyrosine, and L-lysine)
- Dosage Form: Clear, sterile, preservative-free solution pre-filled in single-use glass syringes for convenient self-administration
- Inactive Ingredients: Formulated with pharmaceutical-grade Mannitol to maintain essential tonicity and Water for Injection
Product Specification
| Product Parameter | Details |
| Brand Name | Glatimer Injection |
| Active Ingredient | Glatiramer Acetate |
| Therapeutic Class | Immunomodulators / Disease-Modifying Therapies (DMTs) |
| Common Strengths | 20mg / ml (Once Daily) |
| Primary Indications | Relapsing-Remitting Multiple Sclerosis (RRMS) and Clinically Isolated Syndrome (CIS) |
Mechanism of Action
- Myelin Decoy Mimicry: The four amino acids in glatiramer acetate structurally resemble myelin basic protein, misleading auto-reactive immune cell units.
- Immune System Shift: It modifies the presentation of antigens, inducing a metabolic shift from aggressive, pro-inflammatory T-cells to protective, anti-inflammatory Th2 suppressor cells.
- Suppressing Central Inflammation: These modified suppressor cells successfully cross the blood-brain barrier into the central nervous system. Once inside, they release anti-inflammatory chemicals that actively downregulate the destructive auto-immune assault on the brain and spinal cord myelin sheaths.
Key Benefits
- Significantly lowers the annualized relapse rate (ARR) in adult patients diagnosed with active relapsing-remitting multiple sclerosis.
- Reduces the formation, size, and burden of new active brain or spinal cord lesions as quantified via periodic MRI tracking scans.
- Presents a favorable long-term safety profile with a low risk of systemic organ toxicities or severe opportunistic infections.
Precautions
Important Precautions for Glatimer Injection (Glatiramer Acetate)
Glatimer Injection is used in multiple sclerosis management. Regular monitoring and correct usage are important for safety and effectiveness.
| Precaution Area | Details |
|---|---|
| Allergic Reactions | Stop use if rash or breathing issues occur. |
| Injection Site | Rotate sites to avoid irritation. |
| Heart Symptoms | May cause chest tightness or palpitations. |
| Immune Effects | Can alter immune response. Monitor closely. |
| Infections | Report frequent or unusual infections. |
| Pregnancy | Use only after medical advice. |
| Liver Function | Monitor liver health during therapy. |
Important Safety Advice
- Use exactly as directed without skipping doses
- Learn proper injection technique
- Report chest pain or severe reactions immediately
- Maintain regular follow-up appointments
- Do not change dose without guidance
When to Avoid Glatimer Injection
- Known allergy to Glatiramer Acetate
- Severe hypersensitivity reactions in past use
- Uncontrolled serious medical conditions
Monitoring Requirements
- Injection site condition checks
- Immune response monitoring
- Liver function tests if required
- Observation after initial doses for reactions
- Regular neurological assessment for MS progression
Usage
This specialized disease-modifying therapy requires strict adherence to scheduling and sterile injection techniques to maximize neurological protection and manage localized skin side effects. Patients must be trained by a healthcare professional on how to properly handle and self-administer the pre-filled syringes. Regular medical evaluations are necessary to monitor overall disease progression, track the formation of inflammatory lesions via periodic MRI scans, and evaluate localized tissue health at injection sites.
| Parameter | Clinical Guidelines |
| Standard Dosage | Depending on the prescribed strength: either 20mg administered once daily, or 40mg administered three times a week (at least 48 hours apart). |
| Administration Route | For subcutaneous injection only. Inject into the fatty tissue layer directly underneath the skin. Do not inject into a vein or muscle. |
| Site Rotation | Rotate injection sites daily among approved areas (abdomen, thighs, upper arms, hips). Maintain a detailed log to avoid using the same spot more than once a week. |
| Temperature Prep | Remove one pre-filled syringe from the refrigerator approximately 20 minutes before use. Allow it to reach room temperature naturally to reduce injection sting. |
Uses
Relapsing-Remitting Multiple Sclerosis: Indicated as a long-term treatment to significantly lower the annualized relapse rate and frequency of clinical flare-ups in patients diagnosed with RRMS.
Clinically Isolated Syndrome (CIS): Prescribed to delay the onset of fully defined multiple sclerosis in patients who have experienced their first single episode of neurological symptoms.
Preservation of Myelin Integrity: Utilized to prevent autoimmune cells from damaging the myelin sheaths protecting the brain and spinal cord, thereby reducing the development of active T2 brain lesions.
Delaying Disability Progression: Indicated to help slow down the accumulation of physical impairment and neurological deficits over time in individuals living with relapsing forms of MS.
Side Effects
Possible Side Effects of Glatimer Injection (Glatiramer Acetate)
Glatimer Injection is generally well tolerated in multiple sclerosis treatment, but some patients may experience mild to moderate side effects, especially at the start of therapy.
| Side Effect Type | Details |
|---|---|
| Common Effects | Injection site pain, redness, swelling. |
| Immediate Reactions | Flushing, chest tightness, palpitations. |
| Nervous System | Headache, dizziness. |
| Immune Effects | Increased susceptibility to infections. |
| Respiratory | Shortness of breath in rare cases. |
| General Effects | Fatigue or weakness. |
Common Side Effects
- Injection site redness or pain
- Mild swelling at injection site
- Headache
- Flushing after injection
Less Common But Important Effects
- Chest tightness or pressure
- Fast heartbeat or palpitations
- Shortness of breath
- Fever or signs of infection
When to Be Careful
- Severe allergic reactions
- Persistent chest discomfort
- Difficulty breathing after injection
- Unusual or recurring infections
General Note
- Many side effects reduce with continued use
- Proper injection technique helps minimize reactions
- Report any persistent or severe symptoms promptly
FAQs
Q: What is Glatimer Injection used for?
A: This prescription immunomodulatory medicine is a long-term disease-modifying therapy used to manage relapsing forms of multiple sclerosis and clinically isolated syndrome. It helps lower the frequency of unpredictable relapses and delays physical disability progression.
Q: How does Glatiramer Acetate act as a decoy for the immune system?
A: The drug is a synthetic combination of four amino acids that look exactly like myelin basic protein. By acting as a decoy, it shifts your immune response away from attacking your natural myelin sheaths and induces protective, anti-inflammatory cells instead.
Q: Where should this medication be injected?
A: It must be administered via a subcutaneous injection into the fatty layer directly beneath the skin. Approved areas include the abdomen, thighs, upper arms, and hips.
Q: What is the correct way to store the pre-filled syringes?
A: Store the single-dose glass syringes in the refrigerator between 2 degrees and 8 degrees Celsius inside their original carton to protect them from light. If necessary, you can store them at room temperature for up to one month, but do not freeze them.
Q: What is an immediate post-injection reaction?
A: Minutes after injecting, some patients may experience a temporary flushing, chest tightness, shortness of breath, a rapid heart rate, or intense anxiety. These self-limiting symptoms are usually harmless and go away entirely within 15 to 30 minutes without treatment.
Q: Are there any localized skin problems associated with the needle sites?
A: Yes, common localized side effects include redness, swelling, itching, and pain at the injection site. Over time, repeated shots in the exact same spot can cause permanent localized fat loss or a dent in the skin known as lipoatrophy.
Interactions
Drug Interactions of Glatimer Injection (Glatiramer Acetate)
Glatimer Injection is an immunomodulatory therapy used in multiple sclerosis. It has relatively few known drug interactions, but caution is still required when used with certain medicines.
| Medicine or Product Type | Interaction Details |
|---|---|
| Other Immunomodulators | May increase immune-related effects. |
| Immunosuppressants | Can alter immune response balance. |
| Corticosteroids | May be used together, but monitor response. |
| Vaccines | May reduce immune response to vaccines. |
| Biologic Therapies | May increase risk of immune system changes. |
| Anticancer Drugs | Can increase immune suppression effects. |
Important Interaction Advice
- Inform about all ongoing neurological and immune therapies
- Avoid combining multiple immune-altering medicines without guidance
- Monitor for unusual infections or immune reactions
- Do not self-adjust or combine therapies independently
General Guidance
- Regular monitoring is important during combination therapy
- Vaccine response may be reduced during treatment
- Report fever, infections, or unusual symptoms promptly
- Maintain consistent follow-up for MS management
Additional Note
- Always share complete medication history before starting Glatimer Injection therapy
| Manufacturer | : | Natco Pharma, India |
| Trade Name | : | Copaxone |
| Generic Search | : | Glatiramer Acetate |
| Strength | : | 20mg |
Latest Products
